Pluristem Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PSTI and buy or sell other stocks, ETFs, and their options commission-free!About PSTI
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions.
CEOYaky Yanay, CPA
CEOYaky Yanay, CPA
Employees127
Employees127
HeadquartersHaifa, Haifa
HeadquartersHaifa, Haifa
Founded2001
Founded2001
Employees127
Employees127
PSTI Key Statistics
Market cap30.39M
Market cap30.39M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume9.95K
Average volume9.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$3.33
52 Week low$3.33
Stock Snapshot
With a market cap of 30.39M, Pluristem Therapeutics(PSTI) trades at $3.85. The stock has a price-to-earnings ratio of -1.01.
Pluristem Therapeutics(PSTI) stock opened on 2025-11-05 at —. The price climbed to — and dipped to —.
The Pluristem Therapeutics(PSTI)'s current trading volume is 0, compared to an average daily volume of 9.95K.
During the past year, Pluristem Therapeutics(PSTI) stock moved between $3.33 at its lowest and $7.13 at its peak.
During the past year, Pluristem Therapeutics(PSTI) stock moved between $3.33 at its lowest and $7.13 at its peak.